Corbus Pharmaceuticals Holding
Statements
Cash Flow
Corbus Pharmaceuticals Holding (CRBP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -30 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.2 | -5.3 | -6.6 | -5.7 | -6.3 | -9.1 | -1.6 | -5.6 | -8.8 | -14 | 10 | -16 | -17 | -23 | -28 | -27 | -27 | -18 | -22 | -18 | 0.9 | -9.7 | -11 | -12 | -7.2 | -7.5 | -15 | -7.8 | -7.2 | -6.0 | -8.0 | -8.9 | -14 | -11 | -16 | -17 | -16 | -16 | -26 | -30 | -87 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 | 0.5 | 0.6 | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | 0.2 | 0.2 | 0.2 | 0.4 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | -0.4 | 0.0 | 0.1 | -0.3 | |
| 0.8 | 1.6 | 1.6 | 1.3 | 1.4 | 1.5 | 1.9 | 1.8 | 2.0 | 1.9 | 3.1 | 2.8 | 3.0 | 3.1 | 3.1 | 3.3 | 3.6 | 2.3 | 2.6 | 2.5 | 2.6 | 1.8 | 1.6 | 1.5 | 1.3 | 1.3 | 1.0 | 0.8 | 0.8 | 0.8 | 1.0 | 1.3 | 2.2 | 1.6 | 1.7 | 1.6 | 1.6 | 1.4 | 1.9 | 1.8 | 6.7 | |
| 0.8 | 1.7 | 1.6 | 1.3 | 1.4 | 1.4 | 1.9 | 1.8 | 2.0 | 2.0 | 3.1 | 2.8 | 3.1 | 3.0 | 3.0 | 3.3 | 3.8 | 2.6 | 2.6 | 2.5 | 3.5 | 2.3 | 2.4 | 2.1 | 1.2 | 0.9 | 1.0 | 0.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.3 | 0.5 | -0.8 | 0.2 | -0.9 | -0.8 | 7.8 | 4.5 | 3.6 | 1.1 | 33 | -22 | 0.3 | 0.6 | -1.4 | 7.7 | 3.4 | -13 | -8.9 | -3.4 | -1.1 | -2.3 | -4.0 | -1.5 | 0.0 | 2.0 | 1.4 | -0.1 | 1.8 | 1.0 | -1.5 | 0.5 | -2.0 | -2.6 | -1.0 | 0.1 | 6.2 | 3.8 | -4.3 | 1.2 | 6.9 | |
| 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.6 | 1.3 | 0.7 | 0.1 | 0.2 | 0.1 | 0.2 | 1.2 | 1.3 | 0.5 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | -0.6 | -1.3 | -0.7 | -0.1 | -0.2 | -0.1 | -0.2 | -1.2 | -1.3 | -0.5 | 0.0 | -0.1 | 0.1 | -57 | -13 | 0.3 | -3.2 | 43 | -19 | -6.0 | 12 | 5.5 | 8.8 | 11 | 10 | -98 | -16 | -15 | 8.7 | 18 | 18 | 20 | -57 | 22 | 18 | 3.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.2 | 1.5 | 41 | 0.0 | 0.0 | 38 | 12 | 0.1 | 0.0 | 0.0 | 40 | 0.1 | 0.1 | 0.0 | 46 | 44 | – | – | 63 | 0.1 | – | – | – | – | – | – | 0.0 | 0.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 0.2 | -0.7 | -0.2 | -0.1 | -1.9 | -0.7 | -0.2 | -0.1 | 0.4 | -2.6 | -0.3 | -0.1 | -0.2 | -3.1 | -0.5 | 19 | 0.7 | -2.1 | -0.3 | -0.1 | 0.8 | -0.3 | -0.3 | -0.1 | 0.2 | -0.2 | -0.2 | – | – | – | – | -11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| 0.2 | 1.7 | 41 | -0.1 | -0.1 | 36 | 11 | 0.0 | -0.1 | 0.4 | 38 | -0.2 | 0.0 | 0.8 | 43 | 43 | 47 | 22 | 60 | -0.3 | -0.1 | 0.8 | -0.3 | -0.3 | -0.1 | 0.2 | -0.1 | 0.0 | -0.8 | -1.9 | 107 | 35 | 25 | 0.0 | 0.0 | 0.0 | 2.9 | 75 | – | 9.1 | – | |
| -3.1 | -3.7 | 34 | -5.9 | -6.4 | 26 | 8.3 | -6.3 | -9.0 | -14 | 48 | -17 | -18 | -23 | 15 | 17 | 19 | 3.6 | -19 | -31 | 1.0 | -12 | 32 | -31 | -13 | 4.6 | -9.7 | 1.0 | 2.9 | 2.5 | 0.4 | 9.6 | -4.3 | -2.2 | 1.7 | 1.1 | 6.9 | 1.5 | -3.1 | -2.3 | 3.0 | |
| -3.3 | -5.4 | -6.7 | -5.8 | -6.4 | -9.7 | -2.9 | -6.2 | -9.0 | -14 | 10 | -17 | -18 | -24 | -28 | -27 | -27 | -18 | -22 | -18 | 0.9 | -9.8 | -11 | -12 | -7.2 | -7.5 | -15 | -7.8 | -7.2 | -6.0 | -8.0 | -8.9 | -14 | -11 | -16 | -17 | -16 | -16 | -26 | -30 | -87 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.